|
1
|
Sharafinski ME, Ferris RL, Ferrone S and
Grandis JR: Epidermal growth factor receptor targeted therapy of
squamous cell carcinoma of the head and neck. Head Neck.
32:1412–1421. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
3
|
Chen YP, Chan ATC, Le QT, Blanchard P, Sun
Y and Ma J: Nasopharyngeal carcinoma. Lancet. 394:64–80. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bruce JP, Yip K, Bratman SV, Ito E and Liu
FF: Nasopharyngeal cancer: Molecular landscape. J Clin Oncol.
33:3346–3355. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee AW, Ma BB, Ng WT and Chan AT:
Management of nasopharyngeal carcinoma: Current practice and future
perspective. J Clin Oncol. 33:3356–3364. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wong KCW, Hui EP, Lo KW, Lam WKJ, Johnson
D, Li L, Tao Q, Chan KCA, To KF, King AD, et al: Nasopharyngeal
carcinoma: An evolving paradigm. Nat Rev Clin Oncol. 18:679–695.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Johnson DE, Burtness B, Leemans CR, Lui
VWY, Bauman JE and Grandis JR: Head and neck squamous cell
carcinoma. Nat Rev Dis Primers. 6:922020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bossi P, Chan AT, Licitra L, Trama A,
Orlandi E, Hui EP, Halámková J, Mattheis S, Baujat B, Hardillo J,
et al: Nasopharyngeal carcinoma: ESMO-EURACAN clinical practice
guidelines for diagnosis, treatment and follow-up†. Ann
Oncol. 32:452–465. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kang Y, He W, Ren C, Qiao J, Guo Q, Hu J,
Xu H, Jiang X and Wang L: Advances in targeted therapy mainly based
on signal pathways for nasopharyngeal carcinoma. Signal Transduct
Target Ther. 5:2452020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Suryani L, Lee HPY, Teo WK, Chin ZK, Loh
KS and Tay JK: Precision medicine for nasopharyngeal cancer-a
review of current prognostic strategies. Cancers (Basel).
16:9182024. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kamps R, Brandão RD, Bosch BJ, Paulussen
AD, Xanthoulea S, Blok MJ and Romano A: Next-generation sequencing
in oncology: genetic diagnosis, risk prediction and cancer
classification. Int J Mol Sci. 18:3082017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Segal E, Friedman N, Kaminski N, Regev A
and Koller D: From signatures to models: Understanding cancer using
microarrays. Nat Genet. 37 (Suppl 1):S38–S45. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Paik S, Tang G, Shak S, Kim C, Baker J,
Kim W, Cronin M, Baehner FL, Watson D, Bryant J, et al: Gene
expression and benefit of chemotherapy in women with node-negative,
estrogen receptor-positive breast cancer. J Clin Oncol.
41:3565–3575. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Glinsky GV, Glinskii AB, Stephenson AJ,
Hoffman RM and Gerald WL: Gene expression profiling predicts
clinical outcome of prostate cancer. J Clin Invest. 113:913–923.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dave SS, Wright G, Tan B, Rosenwald A,
Gascoyne RD, Chan WC, Fisher RI, Braziel RM, Rimsza LM, Grogan TM,
et al: Prediction of survival in follicular lymphoma based on
molecular features of tumor-infiltrating immune cells. N Engl J
Med. 351:2159–2169. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hui EP, Ma BBY, Lam WKJ, Chan KCA, Mo F,
Ai QH, King AD, Wong CH, Wong KCW, Lam DCM, et al: Dynamic changes
of post-radiotherapy plasma epstein-barr virus DNA in a randomized
trial of adjuvant chemotherapy versus observation in nasopharyngeal
cancer. Clin Cancer Res. 27:2827–2836. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li T, Chen JX, Fu XP, Yang S, Zhang Z,
Chen KhH and Li Y: microRNA expression profiling of nasopharyngeal
carcinoma. Oncol Rep. 25:1353–1363. 2011.PubMed/NCBI
|
|
18
|
Chua DTT, Nicholls JM, Sham JST and Au
GKH: Prognostic value of epidermal growth factor receptor
expression in patients with advanced stage nasopharyngeal carcinoma
treated with induction chemotherapy and radiotherapy. Int J Radiat
Oncol Biol Phys. 59:11–20. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Camp RL, Dolled-Filhart M and Rimm DL:
X-tile: A new bio-informatics tool for biomarker assessment and
outcome-based cut-point optimization. Clin Cancer Res.
21:7252–7259. 2004. View Article : Google Scholar
|
|
20
|
Pan JJ, Ng WT, Zong JF, Lee SWM, Choi HCW,
Chan LLK, Lin SJ, Guo QJ, Sze HCK, Chen YB, et al: Prognostic
nomogram for refining the prognostication of the proposed 8th
edition of the AJCC/UICC staging system for nasopharyngeal cancer
in the era of intensity-modulated radiotherapy. Cancer.
122:3307–3315. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng R, Zhang S, Zeng H, Wang S, Sun K,
Chen R, Li L, Wei W and He J: Cancer incidence and mortality in
China, 2016. J Natl Cancer Cent. 2:1–9. 2022.PubMed/NCBI
|
|
23
|
Tang LL, Chen YP, Chen CB, Chen MY, Chen
NY, Chen XZ, Du XJ, Fang WF, Feng M, Gao J, et al: The Chinese
society of clinical oncology (CSCO) clinical guidelines for the
diagnosis and treatment of nasopharyngeal carcinoma. Cancer Commun
(Lond). 41:1195–1227. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Z, Chen Y, Su Y, Hu X and Peng X:
Nasopharyngeal carcinoma: Clinical achievements and considerations
among treatment options. Front Oncol. 11:6357372021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee AWM, Ng WT, Chan JYW, Corry J, Mäkitie
A, Mendenhall WM, Rinaldo A, Rodrigo JP, Saba NF, Strojan P, et al:
Management of locally recurrent nasopharyngeal carcinoma. Cancer
Treat Rev. 79:1018902019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Perri F, Della Vittoria Scarpati G,
Caponigro F, Ionna F, Longo F, Buonopane S, Muto P, Di Marzo M,
Pisconti S and Solla R: Management of recurrent nasopharyngeal
carcinoma: current perspectives. Onco Targets Ther. 12:1583–1591.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Siak PY, Khoo AS, Leong CO, Hoh BP and
Cheah SC: Current status and future perspectives about molecular
biomarkers of nasopharyngeal carcinoma. Cancers (Basel).
13:34902021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu H, Tang L, Li Y, Xie W, Zhang L, Tang
H, Xiao T, Yang H, Gu W, Wang H and Chen P: Nasopharyngeal
carcinoma: Current views on the tumor microenvironment's impact on
drug resistance and clinical outcomes. Mol Cancer. 23:202024.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang S, Chen J, Guo Y, Lin H, Zhang Z,
Feng G, Hao Y, Cheng J, Liang P, Chen K, et al: Identification of
prognostic biomarkers for response to radiotherapy by DNA
microarray in nasopharyngeal carcinoma patients. Int J Oncol.
40:1590–1600. 2012.PubMed/NCBI
|
|
30
|
Chen J, Hao Y, Chen J, Huang L, Ao W, Yang
J, Li L, Heng J, Chen Z, Liang W, et al: Colony stimulating
factor-1 receptor promotes proliferation, migration and invasion in
the human nasopharyngeal carcinoma 6-10B cell line via the
phosphoinositide 3-kinase/Akt pathway. Oncol Lett. 16:1205–1211.
2018.PubMed/NCBI
|
|
31
|
Mairhofer M, Steiner M, Salzer U and
Prohaska R: Stomatin-like protein-1 interacts with stomatin and is
targeted to late endosomes. J Biol Chem. 284:29218–29229. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lapatsina L, Brand J, Poole K, Daumke O
and Lewin GR: Stomatin-domain proteins. Eur J Cell Biol.
91:240–245. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang W, MacDonald EM and Koepp DM: The
stomatin-like protein SLP-1 and Cdk2 interact with the F-Box
protein Fbw7-γ. PLoS One. 7:e477362012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zheng Y, Huang C, Lu L, Yu K, Zhao J, Chen
M, Liu L, Sun Q, Lin Z, Zheng J, et al: STOML2 potentiates
metastasis of hepatocellular carcinoma by promoting PINK1-mediated
mitophagy and regulates sensitivity to lenvatinib. J Hematol Oncol.
14:162021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nagaishi M, Kim YH, Mittelbronn M,
Giangaspero F, Paulus W, Brokinkel B, Vital A, Tanaka Y, Nakazato
Y, Legras-Lachuer C, et al: Amplification of the STOML3, FREM2, and
LHFP genes is associated with mesenchymal differentiation in
gliosarcoma. Am J Pathol. 180:1816–1823. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sui Y, Ju C and Shao B: A lymph node
metastasis-related protein-coding genes combining with long
noncoding RNA signature for breast cancer survival prediction. J
Cell Physiol. 234:20036–20045. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang D, Qi H, Li A, Deng F, Xu Y, Hu Z,
Liu Q and Wang Y: Coexisting overexpression of STOML1 and STOML2
proteins may be associated with pathology of oral squamous cell
carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol.
129:591–599.e3. 2020. View Article : Google Scholar : PubMed/NCBI
|
